Applications for up to £20,000 to pump-prime innovative, high-risk and proof-of-concept Oxford-based immuno-oncology research are welcomed. Successful applications should:
- demonstrate genuine integration of immunology and cancer research;
- demonstrate clear line of sight to translation;
- be informed by patient and public involvement;
- increase Oxford’s immuno-oncology capacity;
- be used to leverage follow-on external funding.
This year we also have an additional pot of money reserved for projects that generate synergy between the Oxford BRC Cancer and Vaccine themes.
Please find more information here. The deadline is 5pm Wednesday 11th September.